Regulation & Safety

Finally! FDA holds public review on OTC plan

Finally! FDA holds public review on OTC plan

By Michelle Yeomans

The Food and Drug Administration will hold a public hearing over the next two days to gather input on its' current process for reviewing over-the-counter (OTC) drugs.

FDA under pressure to review sunscreen ingredients

FDA under pressure to review sunscreen ingredients

By Michelle YEOMANS

The Administration is feeling the heat from the (PASS) Coalition, who is urging it to allow Americans to have access to the latest safe and effective sunscreen products available.

EPA expands safer fragrance ingredient list

EPA expands safer fragrance ingredient list

By Michelle Yeomans

The U.S. Environmental Protection Agency (EPA) has added 50 chemicals, including 40 used in fragrances, to its Safer Chemical Ingredient List (SCIL).

Demand for independent accreditation is rising, says NSF expert

Demand for independent accreditation is rising, says NSF expert

By Lucy Whitehouse

In a move which responds to increasing industry focus on regulatory compliance, the NSF, a public health and safety organization, have launched a program to help manufacturers confirm the safety and quality of their products.

Cosmetics research could be subject to IND requirements

Cosmetics research could be subject to IND requirements

By Lucy Whitehouse

The Food and Drug Administration (FDA) has extended the comment period on guidance which could require cosmetics research to secure an Investigational New Drug (IND) before carrying out clinical trials.

REACH to make changes to its nano annex

REACH to make changes to its nano annex

By Michelle Yeomans

The European Commission is finalising its impact assessment of six options for amending the annexes of REACH to better account for nanomaterials.

CfPIE expands certification track to deal with industry concerns

CfPIE expands certification track to deal with industry concerns

By Andrew MCDOUGALL

The Center for Professional Innovation and Education (CfPIE) will expand its offerings to include a new certification track for those in the skin care and cosmetics industries engaged in manufacturing, research, and product development.

Croda awarded for US manufacturing standards

Croda awarded for US manufacturing standards

Two of chemicals company Croda’s US manufacturing sites were awarded Good Manufacturing Practice (GMP) certification by The European Federation for Cosmetic Ingredients (EFfCI) last week.

Ban in place: 2013 a big year for animal testing

Ban in place: 2013 a big year for animal testing

By Andrew MCDOUGALL

It has been a busy twelve months for the cosmetics industry, and in Europe it was a big year concerning animal testing, so Cosmetics Design takes a look at some of the developments.

Regulatory body substance decision

FDA takes action on triclosan after 35 years

By Michelle Yeomans

The Food and Drug Administration has agreed to issue a new rule governing the use of the antimicrobial agent by 2016, a decision that's been in the making since 1978.

New regulation is number one priority, says Kallik CEO

Regulation explained: part 1

New regulation is number one priority, says Kallik CEO

By Andrew MCDOUGALL

In the first of a two part interview with Kallik CEO, Neil Gleghorn, he reveals that the biggest priority for cosmetics companies right now is the new EU Regulation (number 1223/2009) that came into force in July.

NAD advises DermStore discontinue its' eyelash enhancer claims

NAD advises DermStore discontinue its' eyelash enhancer claims

By Michelle Yeomans

The online beauty retailer has been strongly advised by the National Advertising Division to discontinue claims that its’ SmartLash Eyelash Enhancer is “dermatologist recommended” and promotes “Up to a 68% increase in the appearance of lash length.”

EU-US 2nd round of regulation talks focuses on cosmetics

EU-US 2nd round of regulation talks focuses on cosmetics

By Michelle Yeomans

EU and US representatives have concluded their second round of week-long negotiations for the Transatlantic Trade and Investment Partnership where negotiating teams are said to have discussed regulatory compatibility for cosmetics.

AAD identifies 5 unnecessary skin care treatments

AAD identifies 5 unnecessary skin care treatments

By Andrew MCDOUGALL

The American Academy of Dermatology has identified five recommendations about treatments, tests, and procedures related to skin health and care that consumers may not need.